First name
Christopher
Middle name
J
Last name
Harrison

Title

Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.

Year of Publication

2023

Number of Pages

374-376

Date Published

01/2023

ISSN Number

1533-4406

DOI

10.1056/NEJMc2210825

Alternate Title

N Engl J Med

PMID

36630610
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics.

Year of Publication

2021

Number of Pages

Date Published

2021 Aug 05

ISSN Number

2048-7207

Abstract

<p>This clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children was developed by a multidisciplinary panel representing Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA). This guideline is intended for use by healthcare professionals who care for children with AHO, including specialists in pediatric infectious diseases, orthopedics, emergency care physicians, hospitalists, and any clinicians and healthcare providers caring for these patients. The panel's recommendations for the diagnosis and treatment of AHO are based upon evidence derived from topic-specific systematic literature reviews. Summarized below are the recommendations for the diagnosis and treatment of AHO in children. The panel followed a systematic process used in the development of other IDSA and PIDS clinical practice guidelines, which included a standardized methodology for rating the certainty of the evidence and strength of recommendation using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. A detailed description of background, methods, evidence summary and rationale that support each recommendation, and knowledge gaps can be found online in the full text.</p>

DOI

10.1093/jpids/piab027

Alternate Title

J Pediatric Infect Dis Soc

PMID

34350458
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Comparative effectiveness of ceftolozane/tazobactam against pediatric gram-negative drug-resistant isolates.

Year of Publication

2021

Number of Pages

1-6

Date Published

2021 Mar 01

ISSN Number

1973-9478

Abstract

<p>Ceftolozane/tazobactam (C/T), a cephalosporin/beta-lactamase inhibitor combination, was evaluated vs. 10 comparators against 299 pediatric extended-spectrum-cephalosporin-resistant or carbapenem-resistant (ESC-R/CR) Gram-negative Enterobacteriaceae from three freestanding pediatric centers. Isolates were from urine or other sterile sites of children and adolescents through 21 years of age. Susceptibilities were assayed by microbroth dilution via custom Sensititre plates (Thermo Fisher Scientific). Susceptibility was determined using the Sensititre Vizion® system (Thermo Fisher Scientific). Susceptibility breakpoint criteria were those of the Clinical and Laboratory Standards Institute (CLSI) for 2017, except for colistin (EUCAST 2019). Overall, 87.5% isolates were C/T susceptible (MIC ≤2 μg/ml; MIC 0.25/4 μg/ml). Susceptibility to C/T was detected more frequently as compared to all other antimicrobials tested except for colistin (95.4%) and meropenem (97.4%). Percent susceptibility to C/T was high for (91%) and . (73.3%). C/T demonstrated good activity and high potency against most beta-lactam resistant pediatric Enterobacteriaceae from three geographically diverse U.S. regions.</p>

DOI

10.1080/1120009X.2021.1888030

Alternate Title

J Chemother

PMID

33645447
Inner Banner
Publication Image
Inner Banner
Publication Image